Revolution Medicines, Correlations
RVMDW Stock | 0.08 0.03 25.45% |
The current 90-days correlation between Revolution Medicines, and Cheche Group Class is 0.12 (i.e., Average diversification). The correlation of Revolution Medicines, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Revolution Medicines, Correlation With Market
Good diversification
The correlation between Revolution Medicines, Warrant and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines, Warrant and DJI in the same portfolio, assuming nothing else is changed.
Revolution |
Moving together with Revolution Stock
0.7 | INZY | Inozyme Pharma | PairCorr |
0.87 | KURA | Kura Oncology | PairCorr |
0.9 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.94 | ADTX | Aditxt Inc | PairCorr |
0.82 | STRO | Sutro Biopharma | PairCorr |
0.86 | TCRX | Tscan Therapeutics | PairCorr |
0.8 | TERN | Terns Pharmaceuticals | PairCorr |
0.83 | CRNX | Crinetics Pharmaceuticals Buyout Trend | PairCorr |
0.65 | CTMX | CytomX Therapeutics | PairCorr |
0.67 | DAWN | Day One Biopharmaceu | PairCorr |
0.7 | TLKMF | Telkom Indonesia Tbk | PairCorr |
Moving against Revolution Stock
0.71 | OPT | Opthea | PairCorr |
0.7 | GANX | Gain Therapeutics | PairCorr |
0.68 | PFE | Pfizer Inc | PairCorr |
0.65 | PHGE | Biomx Inc | PairCorr |
0.64 | LTRN | Lantern Pharma | PairCorr |
0.61 | CUE | Cue Biopharma | PairCorr |
0.59 | FENC | Fennec Pharmaceuticals | PairCorr |
0.7 | CGTX | Cognition Therapeutics | PairCorr |
0.61 | DBVT | DBV Technologies Earnings Call This Week | PairCorr |
0.36 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.9 | SSNLF | Samsung Electronics | PairCorr |
0.83 | OBI | Ondine Biomedical | PairCorr |
0.64 | GPI | Group 1 Automotive | PairCorr |
0.55 | EC | Ecopetrol SA ADR Sell-off Trend | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Revolution Stock performing well and Revolution Medicines, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Revolution Medicines,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CCG | 3.06 | 0.63 | 0.21 | 11.17 | 2.47 | 6.98 | 35.94 | |||
MCD | 0.79 | 0.11 | 0.14 | 0.31 | 0.77 | 1.91 | 6.87 | |||
IAS | 1.31 | (0.07) | 0.00 | (0.10) | 0.00 | 2.58 | 10.13 | |||
RICK | 1.55 | (0.01) | 0.01 | 0.02 | 1.69 | 2.96 | 15.54 | |||
PLYA | 1.46 | 0.58 | 0.40 | 0.52 | 0.80 | 2.72 | 31.78 | |||
SPMMF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
MOD | 3.14 | (0.62) | 0.00 | (0.51) | 0.00 | 5.40 | 31.68 | |||
TSLA | 3.06 | (0.14) | 0.00 | (0.20) | 0.00 | 6.14 | 16.61 |
Revolution Medicines, Corporate Management
Jack Anders | Chief Officer | Profile | |
Erin Graves | Senior Relations | Profile | |
Walter Reiher | Chief Officer | Profile | |
Margaret JD | Chief Officer | Profile | |
Michael Fischbach | Academic Board | Profile |